Smith & Nephew (SNN) EBITDA Margin (2009 - 2024)
Smith & Nephew (SNN) posted quarterly EBITDA Margin of 50.97% for Q4 2024, up 447.64% on a QoQ basis from 9.31% in Q4 2022.
Smith & Nephew (SNN) EBITDA Margin (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported EBITDA Margin for 15 consecutive years, with 50.97% the latest figure, recorded in Q4 2024.
- Quarterly EBITDA Margin changed N/A year-over-year to 50.97% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 32.29% (changed N/A YoY) and the FY2025 annual result came in at 12.88%, up 157.0% from the prior year.
- EBITDA Margin climbed to 50.97% in Q4 2024 per SNN's latest filing, from 9.31% in the prior quarter.
- Over the last five years, EBITDA Margin for SNN reached as high as 50.97% in Q4 2024 and fell as low as 0.25% in Q4 2020.
- A 4-year average of 17.31% and a median of 9.25% in 2021 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2020 — EBITDA Margin sank 1711 bps — and 2021, when it jumped 944 bps.
- Year by year, EBITDA Margin stood at 0.25% in 2020, then surged by 3843 bps to 9.2% in 2021, then gained by 1 bps to 9.31% in 2022, then jumped by 448 bps to 50.97% in 2024.
- According to Business Quant data, EBITDA Margin over the past three periods registered 50.97%, 9.31%, and 9.2% for Q4 2024, Q4 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 50.97% |
| Dec 31, 2022 | 9.31% |
| Dec 31, 2021 | 9.20% |
| Dec 31, 2020 | -0.25% |
| Dec 31, 2019 | 16.86% |
| Dec 31, 2018 | 15.25% |
| Dec 31, 2017 | 17.72% |
| Dec 31, 2016 | 15.34% |
| Dec 31, 2015 | 19.32% |
| Dec 31, 2014 | 16.35% |
| Sep 30, 2014 | 13.94% |
| Mar 31, 2014 | 18.09% |
| Dec 31, 2013 | 19.26% |
| Mar 31, 2013 | 20.00% |
| Dec 31, 2012 | 19.78% |
| Jun 30, 2012 | 22.60% |
| Mar 31, 2012 | 19.78% |
| Dec 31, 2011 | 20.19% |
| Sep 30, 2011 | 0.00% |
| Jun 30, 2011 | 0.00% |